During his monologue Monday, Jimmy Kimmel raised the possibility that the alleged assassin Tyler Robinson might have been a ...

Imperative Care, Inc. announces positive results from the SYMPHONY-PE Trial evaluating Symphony® Thrombectomy System in the ...

Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase 3 clinical trial in gMG is currently ...

Soleno Therapeutics faces scrutiny over Vykat safety after a patient death. Click here to find out why I rate SLNO a Hold.

The executive who leads Intel’s business with the U.S. government said Tuesday that he has “made the difficult decision” to ...

LandBridge remains heavily dependent on Permian oil activity, with limited concrete progress on data center or green energy ...

MSU will host a DARPAConnect Regional Pop-Up on Wednesday, Sept. 24, from 8:30 a.m. to 4 p.m. in the Strand Union Building.

Protagonist Therapeutics (PTGX) announced new data from the Phase 3 ICONIC-ADVANCE 1 and 2 studies which assessed the superiority of icotrokinra, ...

Relmada Therapeutics ( ($RLMD) ) has shared an announcement. On September 17, 2025, Relmada Therapeutics updated its corporate presentation, ...

Featured presentations showcase the positive Phase 1 healthy volunteer trial results supporting KT-621’s oral, dupilumab-like profileKT-621 ...

The SCSUNAA celebrates alumni achievement at the Bulldog Excellence Awards, honoring Douglas D. Gantt, Renée N. Hamilton, and ...

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that ...